Pharmanex Clinical Study Report

Allen LH. Zinc and micronutrient supplements for children. American Journal of Clinical Nutrition 1998;68:495S-498S.

Anonymous. Knowledge and use of folic acid by women of childbearing age—United States, 1995. MMWR Morb Mortal Wkly Rep 1995;44:716-718.

Bower C. Folate and neural tube defects. Nutr Rev 1995;53 Suppl.S33-S38.

Brophy MH, Siiteri PK. Pyridoxal phosphate and hypertensive disorders of pregnancy. Am J Obset Gynecol 1975;121:1075-1079.

Casparis D, Del Carlo P, Branconi F, Grossi A, Merante D, Gafforio L. Effectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anemia in pregnancy and in the immediate post-partum period: comparison with other liquid or solid formulations containing bivalent or trivalent iron. Minerva Gynecol 1996;48:511-518.

Cook JD. Iron-deficiency anemia. Baillieres Clin Haematol 1994;7:787-804.

Doplin M, Schuette S, Leichtmann G, Lashner B. Tolerability of iron: a comparison of bis-glycino iron II and ferrous sulfate. Clin Ther 1991;13:606-612.

Dreosti IE. Recommended dietary intakes of iron, zinc, and other inorganic nutrients and their chemical form and bioavailability. Nutrition 1993;9:542-545.

Gadowsky SL, Gale K, Wolfe SA, Jory J, Gibson R, O’Connor DL. Biochemical folate, B12, and iron status of a group of pregnant adolescents accessed through the public health system in southern Ontario. J Adolesc Health 1995;16:465-474.

Galloway R, McGuire J. Determinants of compliance with iron supplementation: supplies, side effects, or psychology? Soc Sci Med 1994;39:381-390.

Gordon N. Folate metabolism and neural tube defects. Brain Dev 1995;17:307-311.

Hunt JR. Bioavailability algorithms in setting Recommended Dietary Allowances: lessons from iron, applications to zinc. J Nutr 1996;126:2345S-2353S.

Mahalko JR, Bennion M. The effect of parity and time between pregnancies on maternal hair chromium concentration. Am J Clin Nutr 1976;29:1069-1072.

Oakley GP, Fr., Erickson JD. Vitamin A and birth defects—Continuing caution is needed. N Engl J Med 1995;333:1414-1415.

Olin KL, Stearns DM, Armstrong WH, Keen CL. Comparative retention/absorption of 51 chromium (51Cr) from 51Cr chloride, 51Cr nicotinate and 51Cr picolinate in a rat model. Trace Elem Electrol 1994;11:182-186.

Olivares M, Pizarro F, Pineda O, Name JJ, Hertrampf E, Walter T. Milk inhibits and ascorbic acid favors ferrous bis-glycine chelate bioavailability in humans. Journal of Nutrition 1997;127:1407-1411.

Paroah POD, Connolly KJ. Iodine and brain development. Dev Med Child Neurol 1995;37:744-748.

Pineda O, Ashmead HD, Perez JM, Lemus CP. Effectiveness of iron amino acid chelate on the treatment of iron deficiency anemia in adolescents. Journal of Applied Nutrition 1994;46:2-13.

Rieder MJ. Prevention of neural tube defects with periconceptional folic acid. Clin Perinatal 1994;21:483-503.

Rojas LX, McDowell LR, Cousins RJ et al. Relative bioavailability of two organic and two inorganic zinc sources fed to sheep. J Anim Sci 1995;73:1202-1207.

Rothman KJ, Moore LL, Singer MR, Nguyen USDT, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med 1995;333:1369-1373.

Saner G. The effect of parity on maternal hair chromium concentration and the changes during pregnancy. Am J Clin Nutr 1981;34:853-855.

Saner G. Urinary chromium excretion during pregnancy and its relationship with intravenous glucose loading. Am J Clin Nutr 1981;34:1676-1679.

Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 1995;6:219-226.

Wapnir RA. Copper absorption and bioavailability. American Journal of Clinical Nutrition 1998;67:1054S-60S.

Yen IH, Khoury MJ, Erickson JD, James LM, Waters GD, Berry RJ. The changing epidemiology of neural tube defects. United States, 1968-1989. Am J Dis Child 1992;146:857-861.